| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.646 | 29.044 | 29.986 | 42.936 | 75.575 | 68.007 | 90.860 | 97.872 | 154.823 | 116.696 |
| Total Income - EUR | 26.647 | 29.044 | 29.997 | 47.472 | 80.103 | 88.271 | 85.486 | 99.027 | 167.005 | 178.633 |
| Total Expenses - EUR | 18.345 | 24.745 | 25.671 | 42.926 | 72.152 | 83.724 | 75.712 | 81.272 | 121.282 | 173.615 |
| Gross Profit/Loss - EUR | 8.302 | 4.299 | 4.326 | 4.545 | 7.951 | 4.547 | 9.774 | 17.755 | 45.724 | 5.018 |
| Net Profit/Loss - EUR | 7.503 | 3.937 | 3.887 | 3.700 | 7.171 | 3.731 | 8.922 | 16.911 | 44.298 | 1.272 |
| Employees | 1 | 2 | 2 | 1 | 2 | 2 | 3 | 3 | 3 | 4 |
Check the financial reports for the company - Tovic-Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 20.760 | 13.107 | 16.244 | 58.004 | 186.334 | 181.136 | 183.593 | 206.844 | 191.522 | 170.035 |
| Current Assets | 4.912 | 11.094 | 17.716 | 2.682 | 1.505 | 17.685 | 6.477 | 8.532 | 44.168 | 95.872 |
| Inventories | 615 | 567 | 9.250 | 0 | 0 | 7.649 | 0 | 0 | 1.010 | 48.295 |
| Receivables | 1.985 | 6.724 | 7.023 | 1.249 | 1.221 | 8.473 | 2.534 | 4.984 | 34.685 | 43.635 |
| Cash | 2.312 | 3.803 | 1.444 | 1.433 | 284 | 1.562 | 3.943 | 3.548 | 8.473 | 3.942 |
| Shareholders Funds | 25.014 | 22.906 | 26.519 | 20.739 | 27.915 | 32.141 | 40.360 | 57.396 | 101.520 | 92.676 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 51 | 51 | 51 | 50 |
| Debts | 658 | 1.295 | 7.441 | 39.947 | 159.999 | 166.680 | 149.711 | 157.980 | 134.169 | 173.231 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Tovic-Med Srl